Singapore markets close in 7 hours 7 minutes

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
147.75+2.10 (+1.44%)
At close: 04:03PM EST
147.14 -0.61 (-0.41%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 258.69B
Enterprise value 316.42B
Trailing P/E 19.50
Forward P/E 12.95
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)4.50
Price/book (mrq)16.17
Enterprise value/revenue 5.47
Enterprise value/EBITDA 12.50

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 35.07%
S&P500 52-week change 3-12.46%
52-week high 3175.91
52-week low 3133.05
50-day moving average 3158.46
200-day moving average 3149.50

Share statistics

Avg vol (3-month) 35.4M
Avg vol (10-day) 36.12M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 170.82%
Shares short (12 Jan 2023) 411.96M
Short ratio (12 Jan 2023) 42.24
Short % of float (12 Jan 2023) 40.68%
Short % of shares outstanding (12 Jan 2023) 40.68%
Shares short (prior month 14 Dec 2022) 413.58M

Dividends & splits

Forward annual dividend rate 45.92
Forward annual dividend yield 44.06%
Trailing annual dividend rate 35.64
Trailing annual dividend yield 33.87%
5-year average dividend yield 44.36
Payout ratio 473.73%
Dividend date 314 Feb 2023
Ex-dividend date 411 Jan 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 23.19%
Operating margin (ttm)37.21%

Management effectiveness

Return on assets (ttm)9.27%
Return on equity (ttm)90.65%

Income statement

Revenue (ttm)57.82B
Revenue per share (ttm)32.64
Quarterly revenue growth (yoy)3.30%
Gross profit (ttm)38.88B
Net income avi to common (ttm)13.34B
Diluted EPS (ttm)7.50
Quarterly earnings growth (yoy)24.20%

Balance sheet

Total cash (mrq)11.88B
Total cash per share (mrq)6.72
Total debt (mrq)70B
Total debt/equity (mrq)436.76
Current ratio (mrq)0.93
Book value per share (mrq)9.04

Cash flow statement

Operating cash flow (ttm)22.59B
Levered free cash flow (ttm)20.2B